Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
The American Journal of Gastroenterology|May 18, 2011
Smoking is related to pancreatic fibrosis in humansErwin J M van Geenen, Mark M Smits, Tim C M A Schreuder, et al.
Microcirculation (New York, N.Y. : 1994)|July 18, 2019
Assessment of real-time and quantitative changes in renal hemodynamics in healthy overweight males: Contrast-enhanced ultrasonography vs para-aminohippuric acid clearanceMarcel H A Muskiet, Anna L Emanuel, Mark M Smits, et al.
Cardiovascular Diabetology|April 28, 2022
Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trialCharlotte C van Ruiten, Mark M Smits, Megan D Kok, et al.
Magma (New York, N.Y.)|September 1, 2019
Renal sinus fat and renal hemodynamics: a cross-sectional analysisKarlinde A Spit, Marcel H A Muskiet, Lennart Tonneijck, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|August 16, 2019
GLP-1 receptor agonists do not affect sodium intake: Exploratory analyses from two randomized clinical trialsMark M Smits, Jennifer S Ten Kulve, Liselotte van Bloemendaal, et al.
Hypertension (Dallas, Tex. : 1979)|June 20, 2018
Lixisenatide Versus Insulin Glulisine on Fasting and Postbreakfast Systemic Hemodynamics in Type 2 Diabetes Mellitus PatientsLennart Tonneijck, Marcel H A Muskiet, Jos W Twisk, et al.
BMJ Open|November 21, 2015
Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetesMark M Smits, Lennart Tonneijck, Marcel H A Muskiet, et al.
Diabetes, Obesity & Metabolism|January 18, 2018
Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trialsLennart Tonneijck, Marcel H A Muskiet, Mark M Smits, et al.
Microcirculation (New York, N.Y. : 1994)|April 17, 2021
Skin microvascular function and renal hemodynamics in overweight patients with type 2 diabetes: A cross-sectional studyEmma J Bouman, Mark M Smits, Erik J van Bommel, et al.
Diabetologia|April 3, 2016
Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trialLennart Tonneijck, Mark M Smits, Marcel H A Muskiet, et al.
Pageof 7